The virus gets a head start before anyone knows it's there.
In late April, health workers in the Democratic Republic of the Congo identified a rare strain of Ebola — Bundibugyo — that has since grown into the third-largest outbreak of the virus in recorded history, claiming 223 lives and crossing into Uganda, Europe, and South America through the movement of travelers. The World Health Organisation declared it a global emergency on May 17, invoking the hard lessons of the 2014 West African catastrophe, when silence and delay cost more than 11,000 lives. This time, the international community has moved faster — vaccines are being developed, borders are being screened, and quarantines are being imposed — yet history reminds us that outbreaks of this nature tend to worsen before they relent.
- A virus most people have never heard of — the Bundibugyo strain of Ebola — has quietly grown into a 906-case emergency spanning three continents, with 223 confirmed dead in the DRC alone.
- Healthcare facilities have become amplification zones, and in some areas, political unrest has driven patients out of isolation wards as crowds set fire to hospital tents.
- Suspected cases have surfaced in Italy, Germany, and Brazil, though both Brazilian cases were ultimately attributed to meningitis and malaria — a reminder of how easily Ebola's early symptoms masquerade as other diseases.
- The US, Canada, and others have moved swiftly to restrict travel from affected regions and mandate 21-day quarantines, while over 86 million Australian dollars have been committed to fast-tracking three potential vaccines.
- Models suggest true infection counts may already exceed official figures, and most public health experts expect cases to keep rising before any containment effort takes hold.
On April 24, health workers in the Democratic Republic of the Congo identified the first suspected case of Bundibugyo Ebola — a strain so rare that most people have never encountered its name. Within weeks, the outbreak had grown to 906 suspected cases and 223 deaths, prompting the World Health Organisation to declare a Public Health Emergency of International Concern on May 17. It is only the third time in history that Bundibugyo has driven a major outbreak.
Unlike the more familiar Zaire strain, which kills up to 90 percent of those infected, Bundibugyo carries a fatality rate of around 34 percent. The virus spreads through direct contact with bodily fluids, and its early symptoms — fever, fatigue, sore throat — are easily mistaken for malaria or meningitis. In severe cases, patients develop rashes, seizures, and organ failure. The outbreak echoes the catastrophic 2014–2016 West African crisis in troubling ways: urban density accelerating transmission, healthcare settings becoming hotspots, and traditional burial practices spreading the virus further. In parts of the DRC, political instability has compounded the crisis — crowds have burned hospital tents, forcing infected patients out of isolation.
The virus has already crossed borders. Uganda has reported nine cases and one death. A man treated in Germany, an Italian traveler under monitoring, and two Brazilian cases — both ultimately ruled out as Ebola — have illustrated how quickly a Central African outbreak can ripple across the world. No confirmed cases have appeared outside the DRC and Uganda, but the alerts have been enough to trigger full response protocols in multiple countries.
The international reaction has been markedly faster than in 2014. The United States and Canada have restricted entry from affected nations, airport screening has been reinforced across several countries, and the Coalition for Epidemic Preparedness Innovations has committed over 86 million Australian dollars toward three candidate vaccines. Australia, whose risk remains very low, is monitoring the situation without imposing travel restrictions. Whether this outbreak becomes a contained emergency or a prolonged catastrophe will depend on how effectively public health systems, communities, and international partners hold the line in the weeks ahead.
On April 24, health workers in the Democratic Republic of the Congo identified the first suspected case of Bundibugyo Ebola, a strain so uncommon that most people have never heard its name. By late May, the outbreak had grown to 906 suspected cases and 223 deaths within the DRC alone. On May 17, the World Health Organisation formally declared it a Public Health Emergency of International Concern. What began in Central Africa has now reached three continents, carried by travelers crossing borders and oceans.
Bundibugyo is a rare form of Ebola, which makes this outbreak unusual in its own right. The virus spreads through direct contact with bodily fluids—blood, vomit, feces—of infected people. Early symptoms mimic common illnesses: sore throat, headache, fever, fatigue. Severe cases bring skin rashes, breathing problems, vomiting, diarrhea, abdominal pain, and seizures. What sets Bundibugyo apart from other Ebola strains is its fatality rate. While the more common Zaire strain kills up to 90 percent of those infected, Bundibugyo kills up to 34 percent. That distinction matters little to those who contract it, but it shapes how health systems respond.
The current outbreak is only the third time Bundibugyo has driven a major outbreak in human history. Since Ebola was first identified in humans in 1976, more than 40 outbreaks have occurred worldwide, most in African countries. This one echoes the catastrophic West African outbreak of 2014 to 2016, which killed more than 11,000 people. In both cases, the virus circulated silently for months before anyone sounded an alarm. Initial cases presented with vague symptoms that could be mistaken for malaria, meningitis, or other common diseases. Both outbreaks spread rapidly in cities, where density accelerates transmission. Healthcare settings became amplification points. Political instability and social unrest played a role—in the DRC, crowds have set fire to hospital tents, forcing patients to abandon isolation wards. Traditional burial practices, which involve handling the deceased, accelerated spread in both outbreaks.
The virus has already crossed borders. Uganda, which shares a boundary with the DRC, has reported nine cases and one death. An American man who tested positive while working in the DRC is being treated in Germany and is in stable condition. Italy is monitoring a traveler who returned to Cagliari from the DRC. Brazil is investigating two suspected cases: one person who returned to São Paulo from the DRC with fever (later diagnosed with severe meningitis) and another who arrived in Rio de Janeiro from Uganda with cough, chills, and diarrhea (later found to have malaria, and subsequently tested negative for Ebola). No confirmed Ebola cases have yet appeared in Brazil, but the country has activated its full response protocol—patient isolation, laboratory testing, epidemiological investigation.
The international response has been swift compared to 2014. The United States and Canada are temporarily restricting entry for travelers from the DRC, Uganda, and South Sudan. The US, India, and Mexico are strengthening airport screening and disease monitoring. Some countries have mandated 21-day quarantines for citizens returning from affected areas. The Coalition for Epidemic Preparedness Innovations has committed more than 86 million Australian dollars to fast-track development of three potential vaccines targeting the Bundibugyo strain.
Australia's risk remains very low. The country has imposed no travel restrictions or quarantine requirements for affected nations, though federal health minister Mark Butler says authorities are monitoring the outbreak closely. The trajectory ahead depends on which scenario unfolds. Without effective control measures, cases could surge dramatically—some models suggest the true number of infections by mid-May may have already reached 1,000, well above official counts. In a more optimistic scenario, strengthened public health response, continued international support, rapid vaccine development, and genuine community engagement could bring the outbreak under control. The most likely outcome, based on past experience, is that cases will continue rising before authorities successfully contain the spread. Yet the speed of the international response this time may prevent a catastrophe of the scale witnessed in West Africa a decade ago.
Citas Notables
Federal health minister Mark Butler said authorities are monitoring the outbreak very closely, though Australia's risk of Ebola reaching the country remains very low.— Mark Butler, Australian federal health minister
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that this is the Bundibugyo strain specifically, rather than one of the other Ebola types?
Because Bundibugyo kills fewer people—up to 34 percent instead of 90 percent for Zaire. That sounds like good news, but it also means more people survive to potentially spread it further. A lower fatality rate can sometimes mean longer chains of transmission.
The article mentions that cases were circulating for months before anyone noticed. How does that happen with something as deadly as Ebola?
Early symptoms are generic—fever, headache, sore throat. A person could have Ebola and think they have malaria or the flu. By the time severe symptoms appear, they've already been in contact with family, healthcare workers, maybe traveled. The virus gets a head start.
You mentioned hospital tents being set on fire. What's driving that kind of resistance?
A mix of things. Distrust of institutions, political instability, misinformation about what Ebola is. When a hospital becomes a place where people go and don't come back, communities start to see it as a threat rather than a refuge. That fear is rational, even if it makes containment harder.
The Brazilian cases tested negative for Ebola but positive for other diseases. Does that make them less important to track?
Not at all. They're important precisely because they show how easily Ebola can hide among other illnesses. If someone with Ebola symptoms gets misdiagnosed with malaria or meningitis, they keep moving through the community. That's how outbreaks spread across borders.
Why is the international response faster this time than in 2014?
Partly because we learned hard lessons. The 2014 outbreak killed 11,000 people before the world really mobilized. Now there's institutional memory, better surveillance systems, and countries are more willing to act early. Fear is a teacher.
What happens if the vaccines are developed quickly?
It changes everything. A vaccine could break the chain of transmission, protect healthcare workers, allow people to move safely. But that's still months away, and the outbreak is happening now. The race is real.